Robert T. McNally, PhD, President & CEO of GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel DNA/MVA platform technology, was recently interviewed on the Fox Business Network's The Willis Report and on MONEY with Melissa Francis, discussing GeoVax's Ebola vaccine development program.
http://bit.ly/1E5tm2W
No comments:
Post a Comment